Metabolism Disorder TRIZ Cases

Oral N,N-dimethylglycine administration modifies pig metabolic efficiency, reducing feed conversion ratios without increasing feed costs.

Mucoadhesive polymers anchor lipid matrices to gastric mucosa, extending residence time beyond typical emptying windows to suppress appetite effectively.

Insulinotropic peptide conjugate extends blood half-life via Fc region linkage.

Truncated polypeptides stimulate growth in fish and crustaceans, overcoming species-specific hormone limitations.

Co-formulating alpha-galactosidase A with 1-deoxygalactonojirimycin stabilizes the enzyme structure and enhances lysosomal trafficking.

A lactate powder formulation combines anhydrous calcium lactate with sodium cations to accelerate water dissolution.

Separating fibrous plant material from extracts allows precise concentration control and consistent quality, addressing natural variability in source plants.

Hepatocyte receptor ligands on bipolar lipid nanoparticles direct insulin to the liver, resolving insufficient hepatic delivery while maintaining stability.

Mutant SBEIIa alleles reduce starch branching enzyme activity to increase grain amylose content.

Cyclic fasting mimicking diet induces pancreatic beta-cell regeneration to reverse hyperglycemia without stem cell transplantation complexity.

An antibody binding APRIL modulates proteoglycan interactions to enhance triglyceride clearance.

An educated mononuclear cell product modulates the T cell compartment through umbilical cord blood stem cell co-culture.

GDF3 propeptides and antibodies bind mature GDF3 to antagonize signaling pathways, treating obesity and Type II diabetes.

System adjusts insulin dosage via real-time glucose analysis to minimize hypoglycemic events while maintaining glycemic balance.

Methionine prevents aggregation and oxidation in liquid insulin and GLP-1 agonist formulations, ensuring long-term storage stability.

Radiolabeled somatostatin receptor 2 antagonists prevent agonist-induced internalization, enabling precise tumor imaging with high uptake ratios.

ClpB protein mimics alpha-MSH to activate melanocortin receptors, inducing satiation without complex immune responses.

Polyanionic and polycationic macromolecules form insoluble polyelectrolytic complex structures to create a three-dimensional hybrid gel network.

A pharmaceutical composition combining hesperidin derivatives and caffeine inhibits hepatic lipogenesis to reduce body weight gain.

An artificial lymph node environment replicates natural structures to resolve safety and cost contradictions in dendritic cell vaccines.

CB[7]-PEG stabilizes insulin monomers to accelerate onset and shorten duration, resolving the stability versus speed trade-off in diabetes formulations.

A polyaminoglycoside composition complexing bile salts to prevent intestinal fat absorption.

An energy wave generator emits specific frequencies to lower blood glucose levels.

Cyclized alpha4beta7 antagonist dimer peptides inhibit integrin binding, resolving selectivity issues against alpha4beta1 interference.

Olefin cross-linking stabilizes helical structure, enabling cell penetration and antiviral activity against capsid-containing viruses.

Adjuvants enhance drug permeation through buccal mucosa, bypassing first-pass metabolism to reduce toxicity while accelerating therapeutic onset.

Polymer conjugation extends Exendin plasma half-life to reduce injection frequency and vomiting.

Branched oligoethylene glycol polymers sustain drug release via thermal depot formation while evading anti-PEG antibody clearance.

Composite herbal formulation reduces collagen accumulation to reverse liver fibrosis.

A modified Guizhi Fuling pill formulation reduces total cholesterol and triacylglycerol levels through a simplified decoction process.

Lipidated peptides with modified amino acids enhance protease resistance, extending plasma half-life while maintaining receptor potency.

Amine additives in saxagliptin coatings scavenge formic acid, preventing N-formyl impurity formation and gelatin crosslinking during manufacturing.

Silicon-enriched water-soluble microalgae composition improves blood lipid characteristics and reduces oxidative stress.

Bone morphogenetic protein 10 induces brown fat differentiation without unwanted bone formation, resolving the trade-off between weight loss and side effects.

Covalent insulin dimers act as partial agonists to reduce hypoglycemia risk while maintaining glycemic control.

Adjusting CALCR-based therapeutic dosages improves treatment effectiveness for obesity while maintaining operational simplicity.

Muscle-specific peptide conjugates enhance therapeutic compound uptake in target tissues, reducing systemic toxicity and improving treatment efficacy.

Deuterium substitution reduces cytochrome P450-mediated clearance of cathepsin K inhibitors, extending half-life to treat osteoporosis.

A pharmaceutical composition utilizes herbal extracts to reduce weight gain and lower blood lipid levels.

Isolating lunasin peptides from soy eliminates uncertainty about active components while enabling effective cholesterol management with manageable doses.

Crystalline Pemafibrate forms A through D and amorphous variants improve dissolution profiles and shelf-life while simplifying formulation complexity.

Thermal insulation protects the heater from payload heat loss, ensuring reliable membrane rupture and preventing premature damage during dispensing operations.

Beta-hydroxy-beta-methylbutyrate enhances lipolysis and adipocyte fat oxidation to reduce body weight.

Controlled low-temperature precipitation removes beta-iron hydroxide oxide impurities from iron citrate production.

Exendin analogs activate GLP-1 receptors to prevent structural heart changes and reduce congestive heart failure risk.